1. Bermejo Ramírez, R, Villena Gascó, N, Ruiz Palmero, L, Buces González, E, Arroyo Andújar, J D. 2025. Association of novel ERLIN2 gene variants with hereditary spastic paraplegia. In Human genome variation, 12, 3. doi:10.1038/s41439-024-00305-9. https://pubmed.ncbi.nlm.nih.gov/39762222/
2. Wang, Juan, Zhao, Rongjuan, Cao, Hanshuai, Chang, Xueli, Guo, Junhong. 2023. A novel autosomal dominant ERLIN2 variant activates endoplasmic reticulum stress in a Chinese HSP family. In Annals of clinical and translational neurology, 10, 2139-2148. doi:10.1002/acn3.51902. https://pubmed.ncbi.nlm.nih.gov/37752894/
3. Liu, Yifei, Xie, Pengfei, Jiang, Daishang, Bian, Tingting, Shi, Jiahai. 2020. Molecular and Immune Characteristics for Lung Adenocarcinoma Patients With ERLIN2 Overexpression. In Frontiers in immunology, 11, 568440. doi:10.3389/fimmu.2020.568440. https://pubmed.ncbi.nlm.nih.gov/33424830/
4. Wang, Guohui, Liu, Gang, Wang, Xiaogang, Ethier, Stephen, Yang, Zeng-Quan. 2012. ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways. In BMC cancer, 12, 225. doi:10.1186/1471-2407-12-225. https://pubmed.ncbi.nlm.nih.gov/22681620/
5. Xiao, Bin, Xiang, Qin, Deng, Zihua, Luo, Guoqing, Li, Linhai. . KCNN1 promotes proliferation and metastasis of breast cancer via ERLIN2-mediated stabilization and K63-dependent ubiquitination of Cyclin B1. In Carcinogenesis, 44, 809-823. doi:10.1093/carcin/bgad070. https://pubmed.ncbi.nlm.nih.gov/37831636/
6. Al-Saif, Amr, Bohlega, Saeed, Al-Mohanna, Futwan. . Loss of ERLIN2 function leads to juvenile primary lateral sclerosis. In Annals of neurology, 72, 510-6. doi:10.1002/ana.23641. https://pubmed.ncbi.nlm.nih.gov/23109145/
智鼠故事 
